538 related articles for article (PubMed ID: 12356094)
21. International Conference on Harmonisation; guidance on electronic common technical document specification; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Apr; 68(63):16060-1. PubMed ID: 12674113
[TBL] [Abstract][Full Text] [Related]
22. International Conference on Harmonisation; revised guidance on Q3B(R) Impurities in New Drug Products; Availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Nov; 68(220):64628-9. PubMed ID: 14619944
[TBL] [Abstract][Full Text] [Related]
23. International Conference on Harmonisation; revised guidance on Q3A impurities in new drug substances; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Feb; 68(28):6924-5. PubMed ID: 12583358
[TBL] [Abstract][Full Text] [Related]
24. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 7 on Dissolution Test General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Apr; 75(64):17148-9. PubMed ID: 20383923
[TBL] [Abstract][Full Text] [Related]
25. International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); final guidance for industry on "studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing" (VICH GL23); availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2002 Jan; 67(3):602-3. PubMed ID: 12358039
[TBL] [Abstract][Full Text] [Related]
26. International Cooperation on Harmonisation of Technical requirements for Approval of Veterinary Medicinal Products (VICH); final guidance on " Safety studies for veterinary drug residues in human food: reproduction toxicity testing" (VICH GL22); availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2002 Jan; 67(3):603-5. PubMed ID: 12365425
[TBL] [Abstract][Full Text] [Related]
27. International Conference on Harmonisation; Guidance on Q11 Development and Manufacture of Drug Substances; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2012 Nov; 77(224):69634-5. PubMed ID: 23227566
[TBL] [Abstract][Full Text] [Related]
28. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 4A on Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Apr; 74(66):15991-2. PubMed ID: 19507322
[TBL] [Abstract][Full Text] [Related]
29. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 4B on Microbiological Examination of nonsterile products: Tests for Specified Microorganisms General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Apr; 74(66):15989-90. PubMed ID: 19507320
[TBL] [Abstract][Full Text] [Related]
30. International Conference on Harmonisation; addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2012 May; 77(97):29665-6. PubMed ID: 22616137
[TBL] [Abstract][Full Text] [Related]
31. International Conference on Harmonisation; guidance on the M4 Common Technical Document--Quality: Questions and Answers/Location Issues; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2004 Jun; 69(111):32358-9. PubMed ID: 15188781
[TBL] [Abstract][Full Text] [Related]
32. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 5 on Disintegration Test General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Dec; 74(245):68270-1. PubMed ID: 20344862
[TBL] [Abstract][Full Text] [Related]
33. International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice.
Fed Regist; 1998 Sep; 63(179):49583-98. PubMed ID: 10185190
[TBL] [Abstract][Full Text] [Related]
34. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 8 on Sterility Test General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Dec; 74(244):68068-9. PubMed ID: 20336863
[TBL] [Abstract][Full Text] [Related]
35. International Conference on Harmonisation; guidance on E2E Pharmacovigilance Planning; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2005 Apr; 70(62):16827-8. PubMed ID: 15803631
[TBL] [Abstract][Full Text] [Related]
36. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 10 on Polyacrylamide Gel Electrophoresis General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Apr; 75(69):18509-10. PubMed ID: 20387318
[TBL] [Abstract][Full Text] [Related]
37. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Test for Extractable Volume of Parenteral Preparations General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Jan; 74(6):908-9. PubMed ID: 20333832
[TBL] [Abstract][Full Text] [Related]
38. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
[TBL] [Abstract][Full Text] [Related]
39. International Conference on Harmonisation; draft guidance on E2F Development Safety Update Report; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2008 Aug; 73(151):45462-3. PubMed ID: 18949880
[TBL] [Abstract][Full Text] [Related]
40. International Conference on Harmonisation; Guidance on Q8 Pharmaceutical Development; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2006 May; 71(98):29344-5. PubMed ID: 16749216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
